✦ LIBER ✦

P536 Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease

✍ Scribed by Steenholdt, C.; Bendtzen, K.; Brynskov, J.; Thomsen, O.Ø.; Ainsworth, M.A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa1243 Clinical Implications of Measurin

✍ Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jorn; Thomsen, Ole.; Ainsworth, M 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Clinical Implications of Measuring Drug

✍ Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jørn; Thomsen, Ole \[emptyv]; Ain 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 273 KB

P374 Secondary infliximab treatment fail

✍ Steenholdt, C.; Brynskov, J.; Thomsen, O.; Munck, L.; Fallingborg, J.; Christens 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 89 KB

Tu1142 Secondary Infliximab Treatment Fa

✍ Steenholdt, Casper; Brynskov, Jorn; Thomsen, Ole.; Munck, Lars K.; Fallingborg, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 258 KB